Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Access, yes. sharing, no
<p>The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources.</p>
-
We didnt do any miracles
In principle, generic pharma production could supply developing countries with all the drugs they need. In practice, matters are more difficult. Zafrullah Chowdhury shed light on this complex matter in an interview with Hans Dembowski.
-
Misguided research
Multinational pharma producers are based in rich nations and demand high prices, thus hampering supply of medicine to the developing world. Globally enforced patents serve to protect high prices. At the same time, few new medicines are being developed for the health problems that mostly affect poor countries.
-
What lies underneath: Conserving the oceans genetic resources
The marine realm represents 70% of the surface of the biosphere and contains a rich variety of organisms, including more than 34 of the 36 living phyla, some of which are only found in the oceans.
-
Piper betle Linn. a maligned Pan-Asiatic plant with an array of pharmacological activities and prospects for drug discovery
Piper betle L. is one of the important plants in the Asiatic region which ranks second to coffee and tea in terms of daily consumption. Though the plant is known for abuse, in recent years several reports have been pub- lished on the effects of the plant extract and chemical constituents on different biological activities in vitro and in vivo.
-
Biogas plant gets patent
Thiruvananthapuram: The city-based Biotech Centre for Development of Biogas Technology and other Nonconventional Energy Sources has secured an Indian patent for a portable domestic biowaste treatment biogas plant developed by it. Unlike conventional biogas plants that require cattle dung as feedstock, the plant developed by Biotech can run on household and kitchen waste.
-
Build patents regime on fortified law
SHAMNAD BASHEER & PRASHANT REDDY IN A MOVE WITH SIGNIFICANT RAMIFICAtions for policy-making and participatory democracy, the ministry of commerce recently threw open the issue of compulsory licensing for public debate. The move is a welcome one, as the compulsory licensing (CL) of patents is not just an esoteric intellectual property (IP) issue, but one that has wider ramifications for p
-
Medicines patent pool receives license, backing from US government
The US government
-
India's vision: From scientific pipsqueak to powerhouse
In a new report, a blue-ribbon panel decries India's systemic failure to capitalize on basic research findings. The report, released last week by Prime Minister Manmohan Singh, offers a stinging indictment
-
Compulsory licensing of pharmaceutical patents
It is scandalous that India is yet to issue a single compulsory licence for a drug after the 2005 amendment. (Editorial)